A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.
Psallidas I, Backer V, Kuna P, Palmér R, Necander S, Aurell M, Korsback K, Taib Z, Hashemi M, Gustafson P, Asimus S, Delaney S, Pardali K, Jiang F, Almquist J, Jackson S, Coffman RL, Keeling D, Sethi T.
Psallidas I, et al. Among authors: almquist j.
Am J Respir Crit Care Med. 2021 Feb 1;203(3):296-306. doi: 10.1164/rccm.202001-0133OC.
Am J Respir Crit Care Med. 2021.
PMID: 32809843
Clinical Trial.